Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Two App Marketplaces Ramping Up Consumer Genomics Offerings
...
Register
Defense Dept. Extends Lab-Developed Test Demonstration for TRICARE
...
Register
Celebrity Power to Drive Testing Extends Beyond ‘Angelina Jolie Effect’
From - Diagnostic Testing & Emerging Technologies
The power of celebrity impacts health decisions and drives testing decisions beyond the "Angelina Jolie effect." A study published in the…
Cutting Edge Dx Approvals Threaten FDA’s Fuddy-Duddy Reputation
From - National Intelligence Report
A trio of recent FDA product approvals in the diagnostics space have belied the agency's traditional reputation for resisting medical innovation. Here's the timeline for…
Compliance Quiz: Disciplining Employees for Smoking Pot at Work
From - G2 Compliance Advisor
SITUATION
Your lab is located in Colorado, Washington or another state where recreational and medical marijuana use is legal. But you're still shocked to find…
Decoding Quality Terminology
There is a lot of talk about quality these days, but there is often confusion around quality terminology
Strategic Alliances, Partnerships & Collaborations Analysis – September 2017
...
Register
Mergers, Acquisitions & Asset Sales Analysis – September 2017
...
Register
Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry
...
Register
OIG Work Plan Monthly Review: August 2017
...
Register